T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease

被引:95
作者
Iclozan, Cristina [2 ]
Yu, Yu [2 ]
Liu, Chen [3 ]
Liang, Yaming [2 ]
Yi, Tangsheng [4 ]
Anasetti, Claudio [2 ,5 ]
Yu, Xue-Zhong [1 ,2 ,5 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33512 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Blood & Marrow Transplantat Program, Tampa, FL 33512 USA
[3] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA
[4] City Hope Natl Med Ctr, Grad Sch Biol Sci, Duarte, CA 91010 USA
[5] Univ S Florida, Dept Oncol Sci, Tampa, FL USA
关键词
Th1; Th17; BMT; GVHD; BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; INTERFERON-GAMMA; TH17; CELLS; ROR-GAMMA; DIFFERENTIATION; LINEAGE; AUTOIMMUNE; DISTINCT; IL-17;
D O I
10.1016/j.bbmt.2009.09.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T helper (Th)I cells were considered responsible for the induction of graft-versus-host disease (GVHD), but recently the concept has been challenged. Th17 cells play a critical role in mediating autoimmune diseases, but their role in the pathogenesis of GVHD remains unclear. Herein we compare the ability of in vitro generated Th1 and Th17 cells from C57BL/6 mice to induce GVHD in lethally irradiated BALB/c recipients. Allogeneic Th17 cells had superior expansion and infiltration capabilities in GVHD target organs, which correlated with their increased pathogenicity when compared with nave or Th 1 controls. Th17 cells caused no pathology in the syngeneic recipients, indicating that antigen-activation was required for their pathogenicity. Polarized Th17 cells could not maintain their phenotype in vivo as they produced a significant amount of interferon (IFN)-gamma after being transplanted into allogeneic recipients; however, IFN-gamma was not required for Th17 cell-induced GVHD. Further, we evaluated the pathogenesis of Th17 cells in GVHD by using polyclonal nonprimed CD4 T cells in a clinically relevant allogeneic bone marrow transplantation (BMT) setting. We found that disruption of Th17-differentiation alone by targeting ROR gamma t (Th17-specific transcription factor) had no significant effect on GVHD development. We conclude that Th 17 cells are sufficient but not necessary to induce GVHD. Blot Blood Marrow Transplant 16: 170-178 (2010) (C) 2010 American Society fir Blood and Marrow Transplantation
引用
收藏
页码:170 / 178
页数:9
相关论文
共 35 条
[1]   Haematopoietic cell transplantation as immunotherapy [J].
Appelbaum, FR .
NATURE, 2001, 411 (6835) :385-389
[2]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[3]   Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD) [J].
Blazar, BR ;
Murphy, WJ .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1461) :1747-1767
[4]   IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract [J].
Burman, Angela C. ;
Banovic, Tatjana ;
Kuns, Rachel D. ;
Clouston, Andrew D. ;
Stanley, Amanda C. ;
Morris, Edward S. ;
Rowe, Vanessa ;
Bofinger, Helen ;
Skoczylas, Renae ;
Raffelt, Neil ;
Fahy, Olivier ;
McColl, Shaun R. ;
Engwerda, Christian R. ;
McDonald, Kelli P. A. ;
Hill, Geoffrey R. .
BLOOD, 2007, 110 (03) :1064-1072
[5]   In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations [J].
Carlson, Michael J. ;
West, Michelle L. ;
Coghill, James M. ;
Panoskaltsis-Mortari, Angela ;
Blazar, Bruce R. ;
Serody, Jonathan S. .
BLOOD, 2009, 113 (06) :1365-1374
[6]   Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease [J].
Chen, Xiao ;
Das, Rupali ;
Komorowski, Richard ;
Beres, Amy ;
Hessner, Martin J. ;
Mihara, Masahiko ;
Drobyski, William R. .
BLOOD, 2009, 114 (04) :891-900
[7]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150
[8]   CYTOKINE DYSREGULATION AS A MECHANISM OF GRAFT-VERSUS-HOST DISEASE [J].
FERRARA, JLM .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (05) :794-799
[9]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132
[10]   The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells [J].
Ivanov, Ivaylo I. ;
McKenzie, Brent S. ;
Zhou, Liang ;
Tadokoro, Carlos E. ;
Lepelley, Alice ;
Lafaille, Juan J. ;
Cua, Daniel J. ;
Littman, Dan R. .
CELL, 2006, 126 (06) :1121-1133